Journal article · 2007
Clinical trial endpoints in ovarian cancer: Report of an FDA/ASCO/AACR Public Workshop☆
Gynecologic Oncology, 107(2), 173–176 · Published 1 November 2007 · DOI 10.1016/j.ygyno.2007.08.092
In brief
“Clinical trial endpoints in ovarian cancer: Report of an FDA/ASCO/AACR Public Workshop☆” is a 2007 journal article by Robert C. Bast and 11 co-authors, published in Gynecologic Oncology. OpenAlex counts 62 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 62
- Most cited in
- 2014 (6)
- Field-weighted impact
- 2.97
- References
- 4
- Authors
- 12
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Bast, R. C., Thigpen, J. T., Arbuck, S. G., Basen‐Engquist, K., Burke, L. B., Freedman, R. S., Horning, S. J., Ozols, R. F., Rustin, G. J., Spriggs, D. R., Wenzel, L. B., & Pazdur, R. (2007). Clinical trial endpoints in ovarian cancer: Report of an FDA/ASCO/AACR Public Workshop☆. Gynecologic Oncology, 107(2), 173–176. https://doi.org/10.1016/j.ygyno.2007.08.092
MLA 9
Bast, Robert C., et al. “Clinical trial endpoints in ovarian cancer: Report of an FDA/ASCO/AACR Public Workshop☆.” Gynecologic Oncology, vol. 107, no. 2, 2007, pp. 173–176. https://doi.org/10.1016/j.ygyno.2007.08.092.
Chicago
Bast, Robert C., James Tate Thigpen, Susan G. Arbuck, Karen Basen‐Engquist, Laurie Beth Burke, Ralph S. Freedman, Sandra J. Horning, et al. 2007. “Clinical trial endpoints in ovarian cancer: Report of an FDA/ASCO/AACR Public Workshop☆.” Gynecologic Oncology 107 (2): 173–176. https://doi.org/10.1016/j.ygyno.2007.08.092.
Harvard
Bast, R. C. et al. (2007) ‘Clinical trial endpoints in ovarian cancer: Report of an FDA/ASCO/AACR Public Workshop☆’, Gynecologic Oncology, 107(2), pp. 173–176. doi:10.1016/j.ygyno.2007.08.092.
IEEE
R. C. Bast et al., “Clinical trial endpoints in ovarian cancer: Report of an FDA/ASCO/AACR Public Workshop☆,” Gynecologic Oncology, vol. 107, no. 2, pp. 173–176, 2007, doi: 10.1016/j.ygyno.2007.08.092.
BibTeX
@article{bast2007clinical,
title = {{Clinical trial endpoints in ovarian cancer: Report of an FDA/ASCO/AACR Public Workshop☆}},
author = {Bast, Robert C. and Thigpen, James Tate and Arbuck, Susan G. and Basen‐Engquist, Karen and Burke, Laurie Beth and Freedman, Ralph S. and Horning, Sandra J. and Ozols, Robert F. and Rustin, Gordon J.S. and Spriggs, David R. and Wenzel, Lari B. and Pazdur, Richard},
journal = {Gynecologic Oncology},
year = {2007},
volume = {107},
number = {2},
pages = {173--176},
doi = {10.1016/j.ygyno.2007.08.092},
url = {https://doi.org/10.1016/j.ygyno.2007.08.092}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2012 | 4 | |
| 2013 | 4 | |
| 2014 | 6 | |
| 2015 | 6 | |
| 2017 | 5 | |
| 2018 | 2 | |
| 2019 | 2 | |
| 2020 | 2 | |
| 2022 | 1 | |
| 2025 | 1 |
Its field-weighted citation impact is 2.97: it has been cited 2.97 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- ovarian cancer
- clinical trial endpoints
- surrogate endpoints
- progression-free survival
- overall survival
- CA125
- tumor response biomarkers
- maintenance therapy
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Bast, R. C., Thigpen, J. T., Arbuck, S. G., Basen‐Engquist, K., Burke, L. B., Freedman, R. S., Horning, S. J., Ozols, R. F., Rustin, G. J., Spriggs, D. R., Wenzel, L. B., & Pazdur, R. (2007). Clinical trial endpoints in ovarian cancer: Report of an FDA/ASCO/AACR Public Workshop☆. Gynecologic Oncology, 107(2), 173–176. https://doi.org/10.1016/j.ygyno.2007.08.092
How many times has this paper been cited?
62 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Robert C. Bast, James Tate Thigpen, Susan G. Arbuck, Karen Basen‐Engquist, Laurie Beth Burke, Ralph S. Freedman, Sandra J. Horning, Robert F. Ozols, Gordon J.S. Rustin, David R. Spriggs, Lari B. Wenzel, Richard Pazdur.
What is the DOI of this paper?
10.1016/j.ygyno.2007.08.092, permanently at https://doi.org/10.1016/j.ygyno.2007.08.092. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.